Crossref indexed

Drugs of the Future

Published by Portico.

ISSN 0377-8282
Submit to this journal
01

Aims & scope

Drugs of the Future publishes peer-reviewed research. Manuscripts pass a technical check and a scope check by the handling editor before going to independent reviewers.

02

Recently published

DOI 10.1358/dof.2023.48.3.3567668
Tirzepatide. Dual GLP-1/GIP receptor agonist, Treatment of type 2 diabetes and obesity
Thomas L. Jensen, Andreas Brønden, Kristian Karstoft, David P. Sonne, Mikkel B. Christensen · 2023
DOI 10.1358/dof.2023.48.3.3521861
Pipeline on the Move
Laura Fernández Bertolín · 2023
DOI 10.1358/dof.2023.48.3.3560010
DOI 10.1358/dof.2023.48.3.3500035
DOI 10.1358/dof.2023.48.3.3560011
Tinlarebant. Retinol-binding protein 4 (RBP4) inhibitor, Treatment of Stargardt disease, Treatment of dry age-related macular degeneration
Sabrina Vaccaro, Lorenzo Ferro Desideri, Pietro Bianchi, Aldo Vagge, Riccardo Manocchio, V. Scorcia, Carlo E. Traverso, Federica Calabria, Giuseppe Giannaccare · 2023
DOI 10.1358/dof.2023.48.3.3474539
Ancremonam. Monobactam, Treatment of multidrug-resistant Enterobacteriaceae infections
Mohammad N. Ahmad, Arunava Dasgupta, Sidharth Chopra · 2023
DOI 10.1358/dof.2023.48.2.3400571
DOI 10.1358/dof.2023.48.2.3474010
Journal metrics
Total DOIs3,402
Current DOIs0
Backfile DOIs3,402
Published here0

Publish with us

Five steps, about 15 minutes. You can save and come back at any point.

Submit manuscript